相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival of motor neurone protein is required for normal postnatal development of the spleen
Alison K. Thomson et al.
JOURNAL OF ANATOMY (2017)
ISS-N1 MAKES THE FIRST FDA-APPROVED DRUG FOR SPINAL MUSCULAR ATROPHY
Eric W. Ottesen
TRANSLATIONAL NEUROSCIENCE (2017)
Diverse role of survival motor neuron protein
Ravindra N. Singh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2017)
The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype
Seyyedmohsen Hosseinibarkooie et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience
Manon Hache et al.
JOURNAL OF CHILD NEUROLOGY (2016)
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Richard S. Finkel et al.
LANCET (2016)
Big win possible for Ionis/Biogen antisense drug in muscular atrophy
Ken Garber
NATURE BIOTECHNOLOGY (2016)
The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
W. Arnold et al.
NEUROBIOLOGY OF DISEASE (2016)
Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
Claudia A. Chiriboga et al.
NEUROLOGY (2016)
Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment
Palittiya Sintusek et al.
PLOS ONE (2016)
Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
Suzan M. Hammond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Therapeutic activity of modified U1 core spliceosomal particles
Malgorzata Ewa Rogalska et al.
NATURE COMMUNICATIONS (2016)
Altered Levels of MicroRNA-9,-206, and-132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
Francesco Catapano et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene
Joonbae Seo et al.
PLOS ONE (2016)
Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides
Te-Lin Lin et al.
PLOS ONE (2016)
Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration
W. David Arnold et al.
PLOS ONE (2016)
Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy
Eric W. Ottesen et al.
SCIENTIFIC REPORTS (2016)
A novel human-specific splice isoform alters the critical C-terminus of Survival Motor Neuron protein
Joonbae Seo et al.
SCIENTIFIC REPORTS (2016)
Survival Motor Neuron (SMN) protein is required for normal mouse liver development
Eva Szunyogova et al.
SCIENTIFIC REPORTS (2016)
Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy
Saif Ahmad et al.
JOURNAL OF EXPERIMENTAL NEUROSCIENCE (2016)
Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions
Natalia N. Singh et al.
DNA HABITATS AND THEIR RNA INHABITANTS (2015)
Mechanisms and Regulation of Alternative Pre-mRNA Splicing
Yeon Lee et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy
Natalia N. Singh et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models
Yimin Hua et al.
GENES & DEVELOPMENT (2015)
SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice
Sara E. Gombash et al.
HUMAN MOLECULAR GENETICS (2015)
Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response
Haiyan Zhou et al.
HUMAN MOLECULAR GENETICS (2015)
Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophy
Laurent P. Bogdanik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype
Monica Nizzardo et al.
CLINICAL THERAPEUTICS (2014)
Advances in therapeutic development for spinal muscular atrophy
Matthew D. Howell et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models
Erkan Y. Osman et al.
HUMAN MOLECULAR GENETICS (2014)
Dual Masking of Specific Negative Splicing Regulatory Elements Resulted in Maximal Exon 7 Inclusion of SMN2 Gene
Peng Wen Pao et al.
MOLECULAR THERAPY (2014)
Spinal Muscular Atrophy: Journeying From Bench to Bedside
Tomoyuki Awano et al.
NEUROTHERAPEUTICS (2014)
Electrophysiological biomarkers in spinal muscular atrophy: proof of concept
W. David Arnold et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Spinal muscular atrophy: An update on therapeutic progress
Joonbae Seo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585
Julia Schreml et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice
Haiyan Zhou et al.
HUMAN GENE THERAPY (2013)
An intronic structure enabled by a long-distance interaction serves as a novel target for splicing correction in spinal muscular atrophy
Natalia N. Singh et al.
NUCLEIC ACIDS RESEARCH (2013)
Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy
Chalermchai Mitrpant et al.
PLOS ONE (2013)
Glucose metabolism and pancreatic defects in spinal muscular atrophy
Melissa Bowerman et al.
ANNALS OF NEUROLOGY (2012)
Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72 400 specimens
Elaine A. Sugarman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
Paul N. Porensky et al.
HUMAN MOLECULAR GENETICS (2012)
Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy
Erkan Y. Osman et al.
MOLECULAR THERAPY (2012)
A Multi-Exon-Skipping Detection Assay Reveals Surprising Diversity of Splice Isoforms of Spinal Muscular Atrophy Genes
Natalia N. Singh et al.
PLOS ONE (2012)
TIA1 Prevents Skipping of a Critical Exon Associated with Spinal Muscular Atrophy
Natalia N. Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model
Natalia N. Singh et al.
RNA BIOLOGY (2011)
Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
Marco A. Passini et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity
Sungchan Cho et al.
GENES & DEVELOPMENT (2010)
Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice
Christopher R. Heier et al.
HUMAN MOLECULAR GENETICS (2010)
Cardiac defects contribute to the pathology of spinal muscular atrophy models
Monir Shababi et al.
HUMAN MOLECULAR GENETICS (2010)
Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy
Magali Michaud et al.
NEUROBIOLOGY OF DISEASE (2010)
An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing
Natalia N. Singh et al.
RNA (2010)
Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy
Jason H. Williams et al.
JOURNAL OF NEUROSCIENCE (2009)
Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy
Srinivasan Shanmugarajan et al.
JOURNAL OF PATHOLOGY (2009)
Regulation of SMN Protein Stability
Barrington G. Burnett et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy
Natalia N. Singh et al.
RNA BIOLOGY (2009)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Refined characterization of the expression and stability of the SMN gene products
Jeremie Vitte et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Unfolding the mystery of alternative splicing through a unique method of in vivo selection
Ravindra N. Singh
FRONTIERS IN BIOSCIENCE (2007)
Enhancement of SMN2 Exon 7 inclusion by antisense oligonucleotides targeting the exon
Yimin Hua et al.
PLOS BIOLOGY (2007)
Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis
Veronica Setola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes
Natalia N. Singh et al.
NUCLEIC ACIDS RESEARCH (2007)
Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron
NK Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Defective splicing, disease and therapy: searching for master checkpoints in exon definition
Emanuele Buratti et al.
NUCLEIC ACIDS RESEARCH (2006)
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy
NN Singh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes
NN Singh et al.
RNA (2004)
Deletion of murine Smn Exon 7 directed to liver leads to severe defect of liver development associated with iron overload
JM Vitte et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
CL Lorson et al.
HUMAN MOLECULAR GENETICS (2000)
分享论文
